Cochrane Abstracts
Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Comparison of First‐line Chemotherapy Including Escalated BEACOPP Versus Chemotherapy Including ABVD for People With Early Unfavourable or Advanced Stage Hodgkin Lymphoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma.
Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma. Accessed April 19, 2025.
Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma
Comparison of First‐line Chemotherapy Including Escalated BEACOPP Versus Chemotherapy Including ABVD for People With Early Unfavourable or Advanced Stage Hodgkin Lymphoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
ID - 433061
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433061/all/Comparison_of_first‐line_chemotherapy_including_escalated_BEACOPP_versus_chemotherapy_including_ABVD_for_people_with_early_unfavourable_or_advanced_stage_Hodgkin_lymphoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
